August 05, 2016
3 min watch
Save

VIDEO: Use of checkpoint inhibitors has advanced the treatment of cancer

You've successfully added to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

CLEVELAND — At the Rheumatology Nurses Society Annual Conference, Leonard H. Calabrese, DO, and Elizabeth Kirchner, MSN, CHP, of the Cleveland Clinic, discussed how the proliferation of checkpoint inhibitors has advanced the treatment of cancer. They also talked about the role rheumatology nurses have in the management of immune-related adverse events from checkpoint inhibitors.